A "myriad" of "sizeable" weapons were seized by the police following a stabbing at a Nottingham city centre flat. The ...

Analysts are pulling back from the Healthcare sector as 2 experts expressed today bearish sentiments on Myriad Genetics (MYGN – Research ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q4 CY2024, but sales rose 7.1% year on year to $210.6 million. The ...

Q4 2024 Earnings Call Transcript February 24, 2025 Operator: Good day, and thank you for standing by. Welcome to the Myriad ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced a ...

Myriad Genetics (MYGN) announced that its board has appointed Sam Raha, the company’s current COO, as president and CEO and as a member of the ...

Myriad Genetics Chief Executive Paul J. Diaz will leave the company April 30 to return to private equity firm Cressey & Co., where he will be a managing partner. The former Kindred Healthcare CEO was ...

Equities research analysts at Leerink Partnrs reduced their Q1 2025 earnings estimates for shares of Myriad Genetics in a research report issued on Tuesday, February 25th. Leerink Partnrs analyst P.

DASTAN President Farokh Sarmad and CEO Loxley Fernandes took to the stage at Consensus to share their vision for the ...

The Senate Republican floor leader’s bill was approved unanimously in its committee vote last Thursday. The bill, which now ...

New York State Common Retirement Fund boosted its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by ...